Expression of cell proliferation and apoptosis markers in papillomas and cancers of conjunctiva and eyelid

Annals of the New York Academy of Sciences

Volumn 1030, Issue , 2004, Pages 419-426

  Reszec, Joanna ^a   Sulkowska, Mariola ^a   Koda, Mariusz ^a   Kanczuga Koda, Luiza ^a   Sulkowski, Stanislaw ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Apoptosis; Bak; Basal cell cancer; Bax; Bcl 2; Bcl xl; Cell proliferation; Ki 67; Papilloma; PCNA; Squamous cell cancer

Indexed keywords

CYCLINE; KI 67 ANTIGEN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53;

ADULT; AGED; APOPTOSIS; BASAL CELL CARCINOMA; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONJUNCTIVA TUMOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; EYELID CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAPILLOMA; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

EID: 15044358957     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1329.052     Document Type: Conference Paper

References (12)

1. SJO, N., S. HEEGARDS, J.U. PRAUSE, et al. 2000. Conjunctival papilloma. Acta. Ophtalmol. Scand. 78: 663-665.
2. RESZEC, J., L. KANCZUGA-KODA, J. JANICA, et al. 2003. Evaluation of apoptosis markers in conjunctival and eyelid benign and malignant tumours. Ann. N.Y. Acad. Sci. 1010: 748-751.
3. MIRZA, N., Y.C. NOFSINGER, H. KROGER, et al. 1999. Apoptosis and p53 in inverting papilloma of the sinonasal tract. Am. J. Rhinol. 13: 427-434.
4. RESZEC, J., M. SULKOWSKA, W. FAMULSKI, et al. 2002. The expression of tumorigenesis markers in oral papilloma. Pol. J. Pathol. 53: 195-200.
5. HSIA, J.Y., C.Y. CHEN, C.P. HSU, et al. 2001. Expression of apoptosis-regulating proteins p53, Bcl-2, and Bax in primary resected esophageal squamous cell carcinoma. Neoplasma 48: 483-488.
6. HOTZ, M.A., J. BOSQ, P. ZBAEREN, et al. 1999. Spontaneous apoptosis and the expression of p53 and bcl-2 family proteins in locally advanced head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 125: 417-422.
7. PIATELLI, A., C. RUBINI, M. FIORONI, et al. 2002. Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant lesions of the oral cavity. J. Oral. Maxillofac. Surg. 60: 532-540.
8. PENA, J.C., C.B. THOMPSON, W. RECANT, et al. 1999. Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck. Cancer 85: 164-170.
9. TAKAYAMA, T., M. NAGAO, H. SAWADA, et al. 2001. Bcl-X expression in esophageal squamous cell carcinoma: association with tumor progression and prognosis. J. Surg. Oncol. 78: 116-123.
10. TORZEWSKI, M., M. SARBIA, H. HEEP, et al. 1998. Expression of bclX(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma. Clin. Cancer Res. 4: 577-583.
11. YAO, L., M. IWAI & J. FURUTA. 1999. Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas. Oral Oncol. 35: 56-62.
12. IZAWA, H., N. YONEMITSU, T. SHIN & H. SUGIHARA. 1999. Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia. Auris Nasus Larynx 26: 317-330.